ADVAIR 100/50mcg
Sponsors
GlaxoSmithKline
Conditions
Asthma
Phase 4
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
CompletedNCT01462344
Start: 2011-11-17End: 2015-11-03Updated: 2018-08-06
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
CompletedNCT01475721
Start: 2011-11-18End: 2015-06-23Updated: 2018-08-06